Lymphocyte proliferative responsiveness in 31 patients after an outbreak of toxoplasmosis.
D000293:Adolescent; D000328:Adult; D000941:Antigens / Q000008:administration & dosage; D002648:Child; D003208:Concanavalin A / Q000494:pharmacology; D005260:Female; D006801:Humans; D007244:Infectious Mononucleosis / Q000276:immunology; D037102:Lectins / Q000494:pharmacology; D008213:Lymphocyte Activation / Q000187:drug effects; D008214:Lymphocytes / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D011043:Pokeweed Mitogens / Q000494:pharmacology; D014122:Toxoplasma / Q000276:immunology; D014123:Toxoplasmosis / Q000276:immunology*; D014126:Toxoplasmosis, Ocular / Q000276:immunology
D000941:Antigens; D037102:Lectins; D011043:Pokeweed Mitogens; D003208:Concanavalin A